Section of Rheumatology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, USA.
Faculty of Medicine, Department of Clinical Sciences Lund, Orthopedics, Clinical Epidemiology Unit, Lund University, Lund, Sweden.
Osteoarthritis Cartilage. 2024 Dec;32(12):1628-1635. doi: 10.1016/j.joca.2024.07.010. Epub 2024 Jul 26.
To describe the use of non-steroidal anti-inflammatory drugs (NSAID), opioids, and physiotherapy (PT) among persons with newly diagnosed knee or hip osteoarthritis (OA) with and without NSAID contraindications or precautions.
We used population-based register data to identify adults aged ≥35 as of January 1, 2014, residing in Skåne region (Sweden) between 2004 and 2013, without a previous knee or hip OA diagnosis. Among this cohort, we identified people with incident knee or hip OA diagnosis between 2014 and 2018 and the presence of contraindications to or precautions for oral NSAIDs at the time of OA diagnosis. We estimated the risk of 1) regular oral NSAID use, 2) regular opioid use, and 3) PT during the first year after diagnosis among those with vs. without contraindications or precautions using confounder-adjusted logistic regression with standardization.
We identified 35,173 persons with newly diagnosed OA, of whom 3257 and 8351 had ≥1 contraindication to oral NSAIDs and ≥1 precaution, respectively. Overall, 27% of individuals used oral NSAIDs (with or without opioids or PT), 10% used opioids, and 57% attended PT. Among patients with contraindications, 21% used oral NSAIDs compared to 31% without (absolute adjusted difference -0.06 (95% CIs: -0.08, -0.05)), 53% vs 59% used PT (adjusted difference -0.03 (-0.05, -0.01)), while 14% vs. 8% had prescribed dispensed opioids (adjusted difference 0.02 (0.01, 0.03)). Similar results were observed for those with precautions.
We highlight the need for safer treatment options. People with OA and contraindications/precautions to NSAIDs have a higher risk of opioid use, slightly lower risk of PT use, and continue to be prescribed NSAIDs.
描述新诊断为膝或髋骨关节炎(OA)的患者中,有或无 NSAID 禁忌证或注意事项的患者使用非甾体抗炎药(NSAID)、阿片类药物和物理治疗(PT)的情况。
我们使用基于人群的登记数据,确定 2014 年 1 月 1 日年龄≥35 岁的成年人,在 2004 年至 2013 年期间居住在瑞典斯科讷地区,且无先前的膝或髋 OA 诊断。在该队列中,我们确定了 2014 年至 2018 年期间新诊断为膝或髋 OA 的患者,以及在 OA 诊断时存在口服 NSAID 禁忌证或注意事项的患者。我们使用标准化的混杂因素调整逻辑回归估计了在诊断后 1 年内,有 vs. 无禁忌证或注意事项的患者中:1)常规口服 NSAID 使用,2)常规阿片类药物使用,3)PT 的风险。
我们确定了 35173 名新诊断的 OA 患者,其中 3257 名和 8351 名患者分别存在≥1 项口服 NSAID 禁忌证和≥1 项注意事项。总体而言,27%的患者使用了口服 NSAID(无论是否使用阿片类药物或 PT),10%的患者使用了阿片类药物,57%的患者接受了 PT。在有禁忌证的患者中,21%使用了口服 NSAID,而无禁忌证的患者中则有 31%(绝对调整差异-0.06(95%置信区间:-0.08,-0.05)),53%与 59%接受了 PT(调整差异-0.03(-0.05,-0.01)),而 14%与 8%开具了阿片类药物(调整差异 0.02(0.01,0.03))。对于有注意事项的患者,也观察到了类似的结果。
我们强调需要更安全的治疗选择。有 OA 且有 NSAID 禁忌证或注意事项的患者使用阿片类药物的风险较高,接受 PT 的风险略低,并且继续开具 NSAID。